JPMDL To Consider Abbott-Only MDL For Spinal Cord Stimulator Injury Cases

( August 27, 2026, 9:44 AM EDT) -- WASHINGTON, D.C. — The U.S. Judicial Panel on Multidistrict Litigation will hear arguments Sept. 24 on a request to centralize federal injury cases involving Abbott Laboratories’ spinal cord stimulators XE "spinal cord stimulators" , months after the panel rejected an earlier request to centralize claims against Abbott, Boston Scientific Corp. and other device manufacturers in a single proceeding....